Moderna’s R&D game plan; 2seventy layoffs amid CAR-T slowdown; Covid vaccine boosters get thumbs up; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

This week, we de­buted a re­fresh of our man­u­fac­tur­ing cov­er­age here at End­points News, which will be led by An­na Brown in Lon­don from now on. You can learn more about the new fo­cus from Drew Arm­strong’s note — be sure to check out her sto­ries.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.